Skip to main content

Blood Thinner Recalled

September 27, 2019

Torrent Pharma Inc. is recalling 2472 bottles of anagrelide capsules. According to the September 25, 2019, US Food and Drug Administration (FDA) Enforcement Report, “high out-of-specification results for impurities [were] detected during routine stability testing.” 

The recall affects anagrelide capsules, 0.5 mg, in 100-count bottles (NDC 13668-453-01) from lot BFE2E003 (Exp. 8/31/20). The capsules were distributed throughout the United States and Puerto Rico. 

Torrent Pharma initiated the voluntary recall September 6, 2019. The FDA designated it Class II on September 16, 2019. A Class II designation communicates use of the drug may cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm. 

Anagrelide is a prescription blood thinner used to treat patients with thrombocythemia. 

Jolynn Tumolo

Back to Top